文献速递肾小球疾病遗传性与小管间质肾病

海洛因使用与太平洋西北地区AA型肾淀粉样变相关

Heroin Use Is Associated with AA-Type Kidney Amyloidosis in the Pacific Northwest.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-06-15

在华盛顿州西雅图两家大型医院系统开展病例对照研究,纳入38例活检确诊的肾脏AA淀粉样变患者和72例匹配对照。调整年龄、种族、性别、地点和活检年份后,海洛因使用(过去或现在)与肾脏AA淀粉样变风险估计升高170倍相关(95%CI 28-1018,P<0.001)。病例组中慢性自身免疫性疾病不常见,AA淀粉样变患者进展至ESKD的中位时间为2.4年。

要点

  • 海洛因使用与肾脏AA淀粉样变风险估计升高170倍相关(95%CI 28-1018,P<0.001)。
  • 病例组95%有海洛因使用史,87%有皮肤脓肿,慢性自身免疫病不常见。
  • AA淀粉样变患者进展至ESKD的中位时间为2.4年(IQR 0.5-7.5年)。

核心结论

  • 注射海洛因使用与太平洋西北地区肾脏AA淀粉样变强相关。
  • 海洛因使用的独特方面,特别是地理区域或频繁相关的软组织感染,可能是这种进展性肾脏病的重要原因。

研究设计与样本

  • 病例对照研究,纳入38例活检确诊的肾脏AA淀粉样变患者和72例匹配对照,来自华盛顿州西雅图两家大型医院系统。
  • 通过病历回顾确定海洛因使用模式和持续时间,使用逻辑回归确定关联。

主要发现

  • 病例组中95%有海洛因使用史,87%有皮肤脓肿,76%有muscling证据,27%有skin popping证据。
  • 调整年龄、种族、性别、地点和活检年份后,任何海洛因使用(过去或现在)与肾脏AA淀粉样变风险估计升高170倍相关(95%CI 28-1018,P<0.001)。
  • 病例组中慢性自身免疫性疾病不常见。
  • AA淀粉样变患者进展至ESKD的中位时间为2.4年(IQR 0.5-7.5年)。

临床怎么用

  • 在太平洋西北地区,对肾脏AA淀粉样变患者应询问海洛因使用史。
  • 海洛因使用者的软组织感染可能与肾脏AA淀粉样变相关,需关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: AA-type kidney amyloidosis is classically associated with chronic autoimmune or inflammatory disorders. However, some urban centers have reported a high prevalence of injection drug use among patients with kidney AA amyloidosis. Previous reports lack control groups to quantify associations and most predate the opioid epidemic in the United States. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a case-control study of 38 patients with biopsy-confirmed kidney AA amyloidosis and 72 matched control individuals without this condition from two large hospital systems in Seattle, Washington. We ascertained the pattern and duration of heroin use by medical chart review and determined associations using logistic regression. RESULTS: Among case patients, 95% had a prior history of heroin use, 87% had skin abscesses, and 76% and 27% had evidence of muscling and skin popping, respectively. After adjustment for age, race, sex, site, and year of biopsy, any heroin use (past or current) was associated with an estimated 170-times higher risk of kidney AA amyloidosis compared with no heroin use (95% confidence interval, 28 to 1018 times higher; P<0.001). Chronic autoimmune disorders were uncommon among case patients in this study. The median time to ESKD among patients with AA amyloidosis was 2.4 years (interquartile range, 0.5-7.5 years). CONCLUSIONS: Injection heroin use is strongly associated with kidney AA amyloidosis in the Pacific Northwest. Unique aspects of heroin use, in particular geographic regions or frequent associated soft-tissue infections, may be an important cause of this progressive kidney disease.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Sharma A, Govindan P, Toukatly M, et al. Heroin Use Is Associated with AA-Type Kidney Amyloidosis in the Pacific Northwest. Clin J Am Soc Nephrol. 2018. PMID: 29907621. doi:10.2215/CJN.13641217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。